Selective Estrogen Modulation and Melatonin in Early COVID-19
Status:
Withdrawn
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
This study is a randomized, double-blind, controlled clinical trial to evaluate the effects
of toremifene and/or melatonin in adults with mild COVID-19.